{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T23:27:32Z","timestamp":1790724452410,"version":"4.1.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"29","license":[{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Russian Federal","award":["13411.1008799.13.118"],"award-info":[{"award-number":["13411.1008799.13.118"]}]},{"DOI":"10.13039\/501100002674","name":"Siberian Branch of Russian Academy of Sciences","doi-asserted-by":"publisher","award":["141"],"award-info":[{"award-number":["141"]}],"id":[{"id":"10.13039\/501100002674","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1016\/j.vaccine.2014.05.012","type":"journal-article","created":{"date-parts":[[2014,5,14]],"date-time":"2014-05-14T13:48:28Z","timestamp":1400075308000},"page":"3589-3594","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["A protective chimeric antibody to tick-borne encephalitis virus"],"prefix":"10.1016","volume":"32","author":[{"given":"Ivan K.","family":"Baykov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrey L.","family":"Matveev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oleg V.","family":"Stronin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander B.","family":"Ryzhikov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonid E.","family":"Matveev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marat F.","family":"Kasakin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir A.","family":"Richter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina V.","family":"Tikunova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11\u201312","key":"10.1016\/j.vaccine.2014.05.012_bib0005","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s10354-012-0119-7","article-title":"Tick-borne Encephalitis\u2014still a serious disease?","volume":"162","author":"Kaiser","year":"2012","journal-title":"Wien Med Wochenschr"},{"issue":"29","key":"10.1016\/j.vaccine.2014.05.012_bib0010","doi-asserted-by":"crossref","first-page":"4301","DOI":"10.1016\/j.vaccine.2011.09.114","article-title":"Flaviviruses and flavivirus vaccines","volume":"30","author":"Heinz","year":"2012","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2014.05.012_bib0015","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.ttbdis.2010.10.007","article-title":"Tick-borne encephalitis 2010: epidemiology, risk areas, and virus strains in Europe and Asia\u2014an overview","volume":"2","author":"Suss","year":"2011","journal-title":"Ticks Tick Borne Dis"},{"issue":"11\u201312","key":"10.1016\/j.vaccine.2014.05.012_bib0020","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1007\/s10354-012-0100-5","article-title":"Epidemiology and distribution of tick-borne encephalitis","volume":"162","author":"Dobler","year":"2012","journal-title":"Wien Med Wochenschr"},{"key":"10.1016\/j.vaccine.2014.05.012_bib0025","volume":"vol. 2","year":"2007"},{"key":"10.1016\/j.vaccine.2014.05.012_bib0030","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1146\/annurev.mi.44.100190.003245","article-title":"Flavivirus genome organization, expression, and replication","volume":"44","author":"Chambers","year":"1990","journal-title":"Annu Rev Microbiol"},{"issue":"10","key":"10.1016\/j.vaccine.2014.05.012_bib0035","doi-asserted-by":"crossref","first-page":"5579","DOI":"10.1128\/JVI.65.10.5579-5583.1991","article-title":"The flavivirus envelope protein E: isolation of a soluble form from tick-borne encephalitis virus and its crystallization","volume":"65","author":"Heinz","year":"1991","journal-title":"J Virol"},{"issue":"9627","key":"10.1016\/j.vaccine.2014.05.012_bib0040","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1016\/S0140-6736(08)60800-4","article-title":"Tick-borne encephalitis","volume":"371","author":"Lindquist","year":"2008","journal-title":"Lancet"},{"issue":"Pt 8","key":"10.1016\/j.vaccine.2014.05.012_bib0045","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1099\/vir.0.011437-0","article-title":"Tick-borne encephalitis virus \u2013 a review of an emerging zoonosis","volume":"90","author":"Mansfield","year":"2009","journal-title":"J Gen Virol"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2014.05.012_bib0050","first-page":"3","article-title":"Tick-borne encephalitis vaccines","volume":"2011","author":"Lehrer","year":"2011","journal-title":"J Bioterror Biodef"},{"key":"10.1016\/j.vaccine.2014.05.012_bib0055","unstructured":"http:\/\/rospotrebnadzor.ru\/rss_all\/-\/asset_publisher\/Kq6J\/content\/id\/1805518."},{"issue":"3","key":"10.1016\/j.vaccine.2014.05.012_bib0060","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.idc.2008.03.013","article-title":"Tick-borne encephalitis","volume":"22","author":"Kaiser","year":"2008","journal-title":"Infect Dis Clin North Am"},{"issue":"7","key":"10.1016\/j.vaccine.2014.05.012_bib0065","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.vaccine.2007.11.046","article-title":"After a tick bite in a tick-borne encephalitis virus endemic area: current positions about post-exposure treatment","volume":"26","author":"Br\u00f6ker","year":"2008","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2014.05.012_bib0070","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.virusres.2005.04.007","article-title":"Steps of the tick-borne encephalitis virus replication cycle that affect neuropathogenesis","volume":"111","author":"Mandl","year":"2005","journal-title":"Virus Res"},{"issue":"12","key":"10.1016\/j.vaccine.2014.05.012_bib0075","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1111\/j.1469-0691.2004.01022.x","article-title":"Tick-borne virus diseases of human interest in Europe","volume":"10","author":"Charrel","year":"2004","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.vaccine.2014.05.012_bib0080","first-page":"53","article-title":"Efficiency of use of immunoglobulin preparations for the postexposure prevention of tick-borne encephalitis in Russia (a review of semi-centennial experience)","volume":"1","author":"Pen\u2019evskaia","year":"2010","journal-title":"Med Parazitol (Mosk)"},{"issue":"5995","key":"10.1016\/j.vaccine.2014.05.012_bib0085","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/312643a0","article-title":"Production of functional chimaeric mouse\/human antibody","volume":"312","author":"Boulianne","year":"1984","journal-title":"Nature"},{"issue":"21","key":"10.1016\/j.vaccine.2014.05.012_bib0090","doi-asserted-by":"crossref","first-page":"6851","DOI":"10.1073\/pnas.81.21.6851","article-title":"Chimeric human antibody molecules: mouse antigen-binding domains with human constant region domains","volume":"81","author":"Morrison","year":"1984","journal-title":"Proc Natl Acad Sci USA"},{"issue":"32","key":"10.1016\/j.vaccine.2014.05.012_bib0095","doi-asserted-by":"crossref","first-page":"5265","DOI":"10.1016\/j.vaccine.2010.05.060","article-title":"Chimeric antibodies against tick-borne encephalitis virus","volume":"28","author":"Levanov","year":"2010","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2014.05.012_bib0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0168-1702(93)90011-B","article-title":"Epitope analysis of tick-borne encephalitis (TBE) complex viruses using monoclonal antibodies to envelope glycoprotein of TBE virus (persulcatus subtype)","volume":"30","author":"Tsekhanovskaya","year":"1993","journal-title":"Virus Res"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2014.05.012_bib0105","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0022-1759(99)00184-2","article-title":"Universal PCR amplification of mouse immunoglobulin gene variable regions: the design of degenerate primers and an assessment of the effect of DNA polymerase 3\u2032 to 5\u2032 exonuclease activity","volume":"233","author":"Wang","year":"2000","journal-title":"J Immunol Methods"},{"issue":"3","key":"10.1016\/j.vaccine.2014.05.012_bib0110","first-page":"56","article-title":"Construction of cassette vector plasmids for production of full-size recombinant antibodies","volume":"11","author":"Baykov","year":"2013","journal-title":"Vestnik NGU Vestnik NGU. Seriya: biologiya, klinicheskaya meditsina"},{"key":"10.1016\/j.vaccine.2014.05.012_bib0115","series-title":"Antibody purification handbook","author":"Amersham Pharmacia Biotech","year":"2001"},{"key":"10.1016\/j.vaccine.2014.05.012_bib0120","unstructured":"Netesova NA, Belavin PA, Malygin EG, Rukavishnikov MIu. Recombinant plasmid pGSDEI, encoding protein E of tick-borne encephalitis virus and strain Escherichia coli \u2013 producer of recombinant protein E of tick-borne encephalitis virus. The patent of Russian Federation. No. 2136754.1999."},{"issue":"1","key":"10.1016\/j.vaccine.2014.05.012_bib0125","first-page":"22","article-title":"Protective activity of a bacterial plasmid, bearing the gene for the tick-borne encephalitis virus NS1 nonstructural protein","volume":"46","author":"Timofeev","year":"2001","journal-title":"Vopr Virusol"},{"key":"10.1016\/j.vaccine.2014.05.012_bib0130","first-page":"493","article-title":"A simple method of estimating fifty percent endpoints","volume":"27","author":"Reed","year":"1938","journal-title":"Am J Hyg"},{"issue":"1","key":"10.1016\/j.vaccine.2014.05.012_bib0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00063030-200721010-00001","article-title":"Trends in the development and approval of monoclonal antibodies for viral infections","volume":"21","author":"Reichert","year":"2007","journal-title":"BioDrugs"},{"issue":"5","key":"10.1016\/j.vaccine.2014.05.012_bib0140","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/nm1240","article-title":"Development of a humanized monoclonal antibody with therapeutic potential against West Nile virus","volume":"11","author":"Oliphant","year":"2005","journal-title":"Nat Med"},{"issue":"7","key":"10.1016\/j.vaccine.2014.05.012_bib0145","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1128\/AAC.00147-07","article-title":"Defining limits of treatment with humanized neutralizing monoclonal antibody for West Nile virus neurological infection in a hamster model","volume":"51","author":"Morrey","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"10.1016\/j.vaccine.2014.05.012_bib0150","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1128\/AAC.01178-09","article-title":"Safety and pharmacokinetics of single intravenous dose of MGAWN1, a novel monoclonal antibody to West Nile virus","volume":"54","author":"Beigel","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"issue":"18","key":"10.1016\/j.vaccine.2014.05.012_bib0155","doi-asserted-by":"crossref","first-page":"9227","DOI":"10.1128\/JVI.01087-10","article-title":"Structure and function analysis of therapeutic monoclonal antibodies against dengue virus type 2","volume":"84","author":"Sukupolvi-Petty","year":"2010","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2014.05.012_bib0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.antiviral.2012.02.001","article-title":"A humanized IgG but not IgM antibody is effective in prophylaxis and therapy of yellow fever infection in an AG129\/17D-204 peripheral challenge mouse model","volume":"94","author":"Thibodeaux","year":"2012","journal-title":"Antiviral Res"},{"issue":"2","key":"10.1016\/j.vaccine.2014.05.012_bib0165","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.virol.2011.03.016","article-title":"Treatment of mice with human monoclonal antibody 24h after lethal aerosol challenge with virulent Venezuelan equine encephalitis virus prevents disease but not infection","volume":"414","author":"Hunt","year":"2011","journal-title":"Virology"},{"issue":"42","key":"10.1016\/j.vaccine.2014.05.012_bib0170","first-page":"1837","article-title":"TBE-immunoglobulins \u2013 a critical assessment of efficacy","volume":"124","author":"Aebi","year":"1994","journal-title":"Schweiz Med Wochenschr"},{"issue":"8988","key":"10.1016\/j.vaccine.2014.05.012_bib0175","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/S0140-6736(95)92527-9","article-title":"Tickborne encephalitis despite specific immunoglobulin prophylaxis","volume":"346","author":"Kluger","year":"1995","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.vaccine.2014.05.012_bib0180","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.vaccine.2008.10.087","article-title":"Vaccine-induced enhancement of viral infections","volume":"27","author":"Huisman","year":"2009","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2014.05.012_bib0185","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1084\/jem.146.1.201","article-title":"Dengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibody","volume":"146","author":"Halstead","year":"1977","journal-title":"J Exp Med"},{"issue":"5","key":"10.1016\/j.vaccine.2014.05.012_bib0190","doi-asserted-by":"crossref","first-page":"e1000060","DOI":"10.1371\/journal.ppat.1000060","article-title":"Maturation of West Nile virus modulates sensitivity to antibody-mediated neutralization","volume":"4","author":"Nelson","year":"2008","journal-title":"PLoS Pathog"},{"issue":"4","key":"10.1016\/j.vaccine.2014.05.012_bib0195","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1128\/JVI.71.4.2921-2927.1997","article-title":"Pre- and postexposure protection by passive immunoglobulin but no enhancement of infection with a flavivirus in a mouse model","volume":"71","author":"Kreil","year":"1997","journal-title":"J Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2014.05.012_bib0200","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1023\/A:1018589704981","article-title":"The glycosylation pattern of humanized IgGI antibody (D1.3) expressed in CHO cells","volume":"14","author":"Routier","year":"1997","journal-title":"Glycoconj J"},{"key":"10.1016\/j.vaccine.2014.05.012_bib0205","first-page":"44","article-title":"Glycosylation variations with expression systems and their impact on biological activity of therapeutic immunoglobulins","volume":"1","author":"Raju","year":"2003","journal-title":"Bioprocess Int"},{"key":"10.1016\/j.vaccine.2014.05.012_bib0210","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1186\/1471-2334-13-306","article-title":"May early intervention with high dose intravenous immunoglobulin pose a potentially successful treatment for severe cases of tick-borne encephalitis?","volume":"13","author":"R\u016f\u017eek","year":"2013","journal-title":"BMC Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X14006689?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X14006689?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,19]],"date-time":"2020-08-19T11:34:11Z","timestamp":1597836851000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X14006689"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":42,"journal-issue":{"issue":"29","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["S0264410X14006689"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2014.05.012","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A protective chimeric antibody to tick-borne encephalitis virus","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2014.05.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}